<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Sheffield_episode9 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Sheffield/episode9</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>A template page</TITLE></P><DIV class="container"><DIV id="navbar" class="navbar-collapse collapse"><UL class="nav navbar-nav"><LI class="dropdown" id="li-home"><CENTER><TABLE id="navtable"><TBODY><TR><TD><P>HOME</P></TD></TR></TBODY></TABLE></CENTER></LI><LI class="dropdown"><CENTER><TABLE id="navtable"><TBODY><TR><TD><P>INTRO</P></TD></TR></TBODY></TABLE></CENTER></LI><LI class="dropdown"><CENTER><TABLE id="navtable"><TBODY><TR><TD><P>PROJECT</P></TD></TR></TBODY></TABLE></CENTER></LI><LI class="dropdown"><CENTER><TABLE id="navtable"><TBODY><TR><TD><P>TEAM</P></TD></TR></TBODY></TABLE></CENTER></LI><LI class="dropdown"><CENTER><TABLE id="navtable"><TBODY><TR><TD><P>NOTES</P></TD></TR></TBODY></TABLE></CENTER></LI><LI class="dropdown"><CENTER><TABLE id="navtable"><TBODY><TR><TD><P>JUDGING</P></TD></TR></TBODY></TABLE></CENTER></LI><DIV id="shield"><DIV class="container"><DIV class="heading"><TABLE><TBODY><TR><TH><DIV class="heading-title"><H1 style="padding:0px">THE FUTURE</H1></DIV></TH></TR></TBODY></TABLE></DIV><DIV class="jumbotron"><H2>Introducing our device to the market</H2><P>Misusing antibiotics and manufacturing a device incur costs. The costs of mass producing a device should be less than the costs involved in misusing antibiotics, for the device to have commercial viability in the real world. This could be modelled by taking into account the cost of materials and distribution of a device, and comparing this to the effect antibiotic resistance and misprescription has on a system such as the <BUTTON class="btn btn-lg btn-danger" data-placement="top" data-toggle="popover" title="National Health Service" data-content="The free health institutional service in Britain">NHS</BUTTON>.</P><P>If our device were to become a widespread diagnostic tool, it would require approval from regulatory authorities such as National Institute for Health and Care Excellence (NICE), the Medicines and Healthcare products Regulatory Agency (MHRA) and the International Organisation for Standardization (ISO). Further, we would need to wait for rulings from UK and EU government commissions concerning whether <BUTTON class="btn btn-lg btn-danger" data-placement="top" data-toggle="popover" title="Genetically Modified" data-content="containing genetic material that has been artificially altered so as to produce a desired characteristic.">GM</BUTTON> live bacteria could be safely distributed within a healthcare setting.</P><P>Public and private healthcare providers such as the National Health Service (NHS) and British United Provident Association (Bupa) should be consulted as these would be the end-users. We could further improve the device by conducting widespread trials in partnership with our end-users.</P></DIV></DIV></DIV></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>